Aurora Cannabis Inc (NASDAQ: ACB) closed the day trading at $3.84 up 5.49% from the previous closing price of $3.64. In other words, the price has increased by $+0.2000 from its previous closing price. On the day, 3587512 shares were traded.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Ratios:
For a better understanding of ACB, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.45 and its Current Ratio is at 3.79. In the meantime, Its Debt-to-Equity ratio is 0.20 whereas as Long-Term Debt/Eq ratio is at 0.15.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ACB now has a Market Capitalization of 207.90M and an Enterprise Value of 174.50M. As of this moment, Aurora’s Price-to-Earnings (P/E) ratio for their current fiscal year is 0.42. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.30 while its Price-to-Book (P/B) ratio in mrq is 0.47. Its current Enterprise Value per Revenue stands at 0.82 whereas that against EBITDA is -0.11.
Stock Price History:
Over the past 52 weeks, ACB has reached a high of $11.50, while it has fallen to a 52-week low of $2.84. The 50-Day Moving Average of the stock is 3.7222, while the 200-Day Moving Average is calculated to be 4.9193.
Shares Statistics:
Over the past 3-months, ACB traded about 1.01M shares per day on average, while over the past 10 days, ACB traded about 2.25M shares per day. A total of 34.53M shares are outstanding, with a floating share count of 15.59M. Insiders hold about 0.88% of the company’s shares, while institutions hold 30.36% stake in the company. Shares short for ACB as of Feb 29, 2024 were 3.55M with a Short Ratio of 3.53, compared to 3.62M on Jan 31, 2024.
Earnings Estimates
Current recommendations for the stock of the company come from 2 analysts. On average, analysts expect EPS of -$0.17 for the current quarter, with a high estimate of -$0.04 and a low estimate of -$0.3, while EPS last year was -$1.48. The consensus estimate for the next quarter is -$0.2, with high estimates of -$0.2 and low estimates of -$0.2.
Analysts are recommending an EPS of between -$0.07 and -$1.63 for the fiscal current year, implying an average EPS of -$0.93. EPS for the following year is -$0.32, with 3 analysts recommending between -$0.07 and -$0.73.
Revenue Estimates
4 analysts predict $51.79M in revenue for the current quarter. It ranges from a high estimate of $53.8M to a low estimate of $50.97M. As of the current estimate, Aurora Cannabis Inc’s year-ago sales were $46.86M, an estimated increase of 10.50% from the year-ago figure.
Based on 4 analysts’ estimates, the company’s revenue will be $236.62M in the next fiscal year. The high estimate is $249.7M and the low estimate is $224.36M. The average revenue growth estimate for next year is up 17.30% from the average revenue estimate for this year.
